Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Real-World Use of Recombinant Von Willebrand Factor in People with Clinically Severe Congenital Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe VWD

Robert F. Sidonio, Angela C Weyand, Tammuella Chrisentery-Singleton, Martin Chandler, Haduwa Momoh, Priscilla Driscoll-Shempp, Bethany Jones, Natalia Nieto, Jorge Caicedo

Blood (2023) 142 (Supplement 1): 2613.

https://doi.org/10.1182/blood-2023-174729

Published: 2023

Journal Articles

Facilitators and Barriers to Accessing Antifibrinolytic and Iron Therapies for Patients Who Menstruate - a Global Healthcare Provider Survey

Carine Bekdache, Heather Vandermeulen, Grace Tang, Angela C Weyand, Michelle Sholzberg

Blood (2023) 142 (Supplement 1): 5071.

https://doi.org/10.1182/blood-2023-190501

Published: 2023

Journal Articles

Evaluating Sex-Based Hemoglobin Reference Intervals Using Strict Definitions of Health

Lauren E. Merz, Alexander Chaitoff, Angela C Weyand, Michael Fralick, Michelle Sholzberg

Blood (2023) 142 (Supplement 1): 1084.

https://doi.org/10.1182/blood-2023-174774

Published: 2023

Journal Articles

Evaluating Hemoglobin Thresholds on the Basis of Sex: Preliminary Insights from a Systematic Review

Ingrid Blydt-Hansen, Vidushi Swarup, Teruko Kishibe, Carine Bekdache, Mark A. Crowther, Angela C Weyand, Grace Tang, Michelle Sholzberg

Blood (2023) 142 (Supplement 1): 7200.

https://doi.org/10.1182/blood-2023-190173

Published: 2023

Journal Articles

Hemophilia A Research Program (HARP): A Novel Study Design for a Multicenter and Decentralized Prospective Observational Longitudinal Cohort Study in Hemophilia A

Jill M Johnsen, Shannon L Meeks, Grier P Page, Bhavya S Doshi, Marian T Sullivan, Mary-Anne Ardini, Angela C Weyand, Lynn Malec

Blood (2023) 142 (Supplement 1): 5494.

https://doi.org/10.1182/blood-2023-191010

Published: 2023

Journal Articles

Quality of Life in Patients with Clinically Severe Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe Von Willebrand Disease (VWD)

Angela C. Weyand, Martin Chandler, Carol Fedor, Michael Recht, Robert F. Sidonio, Jr.

Blood (2022) 140 (Supplement 1): 5600–5602.

https://doi.org/10.1182/blood-2022-163302

Published: 2022

Journal Articles

Efficacy of Efanesoctocog Alfa on Physical Functioning: Results from the XTEND-1 Phase 3 Clinical Trial in Previously Treated Patients with Hemophilia A

Amanda Wilson, Nana Kragh, Jennifer Dumont, Jerome Mshijid, Annemieke Willemze, Linda Bystricka, Chuanwu Zhang, Angela C. Weyand, Kathelijn Fischer, Victor Jimenez-Yuste

Blood (2022) 140 (Supplement 1): 5595–5596.

https://doi.org/10.1182/blood-2022-167542

Published: 2022

Journal Articles

Characteristics and Bleeding Behavior of Females with Mild Hemophilia A: Longitudinal Study from Picnichealth Hemophilia A Database

Angela C. Weyand, Hwai Jing Hiew, Yanrong Jiang, Athanasios Siadimas, Francis Nissen, Gillian Hanson, Emily Cibelli, Katya Moreno, Hanlu Zhang, Anjali Sharathkumar

Blood (2022) 140 (Supplement 1): 61–62.

https://doi.org/10.1182/blood-2022-157727

Published: 2022

Journal Articles

Characteristics and Healthcare Utilization of Patients with Mild or Moderate Hemophilia A in the US - an Analysis from the Picnichealth Cohort

Anjali Sharathkumar, Yanrong Jiang, Hwai Jing Hiew, Athanasios Siadimas, Francis Nissen, Gillian Hanson, Emily Cibelli, Katya Moreno, Johnny Wharton, Angela C. Weyand

Blood (2022) 140 (Supplement 1): 2762–2763.

https://doi.org/10.1182/blood-2022-157712

Published: 2022

Journal Articles

Bleeding in Patients with Clinically Severe Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe Von Willebrand Disease (VWD)

Angela C. Weyand, Martin Chandler, Carol Fedor, Kenneth D. Friedman, Sweta Gupta, Kristina M. Haley, Chunla He, Nikki Hirsh, Salley Pels, Jonathan C. Roberts, Tung T. Wynn, Robert F. Sidonio, Jr.

Blood (2021) 138 (Supplement 1): 3183.

https://doi.org/10.1182/blood-2021-145631

Published: 2021

Journal Articles

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Associated with Enoxaparin Therapy in a Pediatric Patient

Aarti Kamat, Mary McGrath, Angela C. Weyand

Blood (2021) 138 (Supplement 1): 4269.

https://doi.org/10.1182/blood-2021-145763

Published: 2021

Journal Articles

Bleeding in Patients with Clinically Severe Von Willebrand Disease: Preliminary Results of Athn 9, a Natural History Study of the Safety, Effectiveness, and Practice of Treatment for People with Severe Von Willebrand Disease (VWD)

Angela C. Weyand, MD, Kenneth D Friedman, MD, Sweta Gupta, MD, Kristina M. Haley, DO, Chunla He, Salley Pels, MD, Jonathan C. Roberts, MD, Crystal Watson, BS, Robert F. Sidonio, Jr., MD MSc.

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-137124

Published: 2020

Journal Articles

The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study

Julie Jaffray, MD, Robert F. Sidonio, Jr., MD MSc, Jemily Malvar, MS, Janice M Staber, MD, Kristina M. Haley, DO, Amy Stillings, Angela C. Weyand, MD, Sarah H. O'Brien, MD, Peter A. Kouides, MD

Blood (2019) 134 (Supplement_1): 628.

https://doi.org/10.1182/blood-2019-122379

Published: 2019

Journal Articles

Assessing the Safety of Various VWF Regimens in Patients with Clinically Severe VWD: A Natural History Study

Robert F. Sidonio, Jr., MD MSc, Angela C. Weyand, MD, Dunlei Cheng, PhD, Crystal Watson

Blood (2019) 134 (Supplement_1): 1132.

https://doi.org/10.1182/blood-2019-128318

Published: 2019

Journal Articles

New therapies for hemophilia

Angela C. Weyand, Steven W. Pipe

Blood (2019) 133 (5): 389–398.

https://doi.org/10.1182/blood-2018-08-872291

Published: 2019

Journal Articles

Surprisingly Rapid Onset of Estrogen-Induced Venous Thrombosis in an Animal Model

Xinge Yu, PhD, Angela C. Weyand, MD, Jordan A. Shavit, MDPhD

Blood (2018) 132 (Supplement 1): 418.

https://doi.org/10.1182/blood-2018-99-120325

Published: 2018

Journal Articles

Genome Editing of Factor V in Zebrafish Embryos Results in a Severe Hemostatic Defect without Spontaneous Hemorrhage

Angela C Weyand, MD, Steve J Grzegorski, Jordan A. Shavit, MD PhD

Blood (2016) 128 (22): 2565.

https://doi.org/10.1182/blood.V128.22.2565.2565

Published: 2016

NARROW

Real-World Use of Recombinant Von Willebrand Factor in People with Clinically Severe Congenital Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe VWD

Facilitators and Barriers to Accessing Antifibrinolytic and Iron Therapies for Patients Who Menstruate - a Global Healthcare Provider Survey

Evaluating Sex-Based Hemoglobin Reference Intervals Using Strict Definitions of Health

Evaluating Hemoglobin Thresholds on the Basis of Sex: Preliminary Insights from a Systematic Review

Hemophilia A Research Program (HARP): A Novel Study Design for a Multicenter and Decentralized Prospective Observational Longitudinal Cohort Study in Hemophilia A

Quality of Life in Patients with Clinically Severe Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe Von Willebrand Disease (VWD)

Efficacy of Efanesoctocog Alfa on Physical Functioning: Results from the XTEND-1 Phase 3 Clinical Trial in Previously Treated Patients with Hemophilia A

Characteristics and Bleeding Behavior of Females with Mild Hemophilia A: Longitudinal Study from Picnichealth Hemophilia A Database

Characteristics and Healthcare Utilization of Patients with Mild or Moderate Hemophilia A in the US - an Analysis from the Picnichealth Cohort

Bleeding in Patients with Clinically Severe Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe Von Willebrand Disease (VWD)

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Associated with Enoxaparin Therapy in a Pediatric Patient

Bleeding in Patients with Clinically Severe Von Willebrand Disease: Preliminary Results of Athn 9, a Natural History Study of the Safety, Effectiveness, and Practice of Treatment for People with Severe Von Willebrand Disease (VWD)

The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study

Assessing the Safety of Various VWF Regimens in Patients with Clinically Severe VWD: A Natural History Study

New therapies for hemophilia

Surprisingly Rapid Onset of Estrogen-Induced Venous Thrombosis in an Animal Model

Genome Editing of Factor V in Zebrafish Embryos Results in a Severe Hemostatic Defect without Spontaneous Hemorrhage

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only